302 Using the 21-gene Breast Cancer Assay in Adjuvant Decision-making in ER-positive (ER+) Early Breast Cancer (EBC) is Cost-effective: Results of a Large Prospective German Multicenter Study

Authors :: J-U Blohmer
Thorsten Kühn
Wolfgang Eiermann
K. Friedrichs
M Warm
A. Benkow
Mahdi Rezai
Sherko Kümmel
Source :: European Journal of Cancer. 48:S130
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
medicine.disease
language.human_language
German
Breast cancer
Multicenter study
Internal medicine
medicine
language
business
Adjuvant
Early breast cancer

Full Text Access

Tools